Oyster Calcium Carbonate Chewable Tablets

This product is involved in the formation of bones and the reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism and reducing the permeability of capillaries.

The main component is calcium carbonate.

This product is a tablet with added coloring and flavoring agents.

Used to prevent and treat calcium deficiency diseases such as osteoporosis, tetany, bone dysplasia, rickets, and as calcium supplement for children, pregnant and lactating women, menopausal women, and the elderly.

Oral administration: 100-200 mg (calculated as calcium) at a time, 3 times a day, chew and swallow.

1. Belching, constipation, and abdominal distension may occur. 2. Hypercalcemia and renal insufficiency may occur occasionally. 3. Excessive and long-term use may cause rebound gastric acid secretion.

It is contraindicated in patients with hypercalcemia, hypercalciuria, calcium-containing kidney stones, or a history of kidney stones.

Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Pregnant and lactating women generally need calcium supplements, but should follow the doctor's advice. Precautions for the elderly: Not yet clear.

1. This product should not be used in combination with digitalis drugs. 2. Drinking large amounts of alcoholic and caffeinated beverages and smoking large amounts of cigarettes will inhibit the absorption of calcium. 3. Eating large amounts of fiber-rich foods can inhibit the absorption of calcium, because calcium combines with cellulose to form compounds that are not easily absorbed. 4. When this product is used together with phenytoin sodium and tetracyclines, the absorption of both is reduced. 5. Vitamin D, contraceptives, and estrogen can increase calcium absorption. 6. When aluminum-containing antacids are taken with this product, aluminum absorption increases. 7. When this product is used in combination with thiazide diuretics, hypercalcemia is likely to occur (due to increased renal tubular calcium reabsorption). 8. When this product is used in combination with potassium-containing drugs, attention should be paid to the occurrence of arrhythmias. 9. If used with other drugs at the same time, drug interactions may occur. Please consult a physician or pharmacist for details.

seal

150mg (calculated as Ca)

24 months

Heilongjiang Linhaixueyuan Pharmaceutical Co., Ltd.

• Founded in:

  2004-01-12

• Address:

  Binxi Economic and Technological Development Zone, Binxi Town, Bin County, Harbin

• Tax NO.:

  912301257660088580

• Registered Funds:

  8.9 million yuan

• Email:

  Log in to view